BARCLAYS PLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,531
+157.6%
241,261
+85.3%
0.00%
+200.0%
Q2 2023$2,147
+38.2%
130,228
+49.5%
0.00%0.0%
Q1 2023$1,554
-70.8%
87,118
-52.3%
0.00%
-50.0%
Q4 2022$5,317
-99.9%
182,599
+11.1%
0.00%
-50.0%
Q3 2022$4,027,000
+10225.6%
164,353
+1669.1%
0.00%
Q2 2022$39,000
-84.1%
9,290
-56.2%
0.00%
Q1 2022$245,000
-77.0%
21,199
-80.2%
0.00%
Q4 2021$1,066,000
+131.2%
106,938
+203.0%
0.00%
Q3 2021$461,000
+27.0%
35,294
+90.9%
0.00%
Q2 2021$363,000
-77.0%
18,488
-75.1%
0.00%
-100.0%
Q1 2021$1,581,000
+53.0%
74,283
+113.7%
0.00%0.0%
Q4 2020$1,033,000
-50.9%
34,756
-64.2%
0.00%0.0%
Q3 2020$2,105,000
-7.3%
97,125
-4.6%
0.00%
-50.0%
Q2 2020$2,270,000
+59.1%
101,851
+8.7%
0.00%
+100.0%
Q1 2020$1,427,000
-51.4%
93,724
-26.7%
0.00%
-50.0%
Q4 2019$2,935,000
+871.9%
127,847
+815.4%
0.00%
Q3 2019$302,000
-25.6%
13,966
-24.5%
0.00%
Q2 2019$406,000
-24.3%
18,487
-5.3%
0.00%
Q1 2019$536,000
+495.6%
19,523
+487.0%
0.00%
Q4 2018$90,000
-53.4%
3,326
-49.8%
0.00%
Q3 2018$193,000
+370.7%
6,627
+400.2%
0.00%
Q2 2018$41,000
-51.2%
1,325
-68.2%
0.00%
Q1 2018$84,000
+121.1%
4,168
+219.1%
0.00%
Q4 2017$38,0001,3060.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders